ePrints

Items where Author is "Kluetz, PG"

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | No Grouping
Jump to: Article
Number of items: 12.

Article

Fiero, MH, Roydhouse, J, Vallejo, J, King-Kallimanis, B, Kluetz, PG and Sridhara, R 2019 , 'US Food and Drug Administration review of statistical analysis of patient-reported outcomes in lung cancer clinical trials approved between January, 2008, and December, 2017' , Lancet Oncology, vol. 20, no. 10 , e582-e589 , doi: https://doi.org/10.1016/S1470-2045(19)30335-3.

King-Kallimanis, BL, Howie, LJ, Roydhouse, J, Singh, H, Theoret, MR, Blumenthal, GM and Kluetz, PG 2019 , 'Patient reported outcomes in anti-PD-1/PD-L1 inhibitor immunotherapy registration trials: FDA analysis of data submitted and future directions' , Clinical Trials, vol. 16, no. 3 , pp. 322-326 , doi: https://doi.org/10.1177/1740774519836991.

Roydhouse, J, Gutman, R, Bhatnagar, V, Kluetz, PG, Sridhara, R and Mishra-Kalyani, PS 2019 , 'Analyzing patient-reported outcome data when completion differs between arms in open-label trials: an application of principal stratification' , Pharmacoepidemiology and Drug Safety, vol. 28, no. 10 , pp. 1386-1394 , doi: https://doi.org/10.1002/pds.4875.

Roydhouse, J ORCID: 0000-0002-8025-5841, Gutman, R, Bhatnagar, V, Kluetz, PG, Sridhara, R and Mishra-Kalyani, PS 2019 , 'Analyzing patient-reported outcome data when completion differs between arms in open-label trials: an application of principal stratification' , Pharmacoepidemiology and Drug Safety, vol. 28, no. 10 , pp. 1386-1394 , doi: https://doi.org/10.1002/pds.4875.

Roydhouse, J, King-Kallimanis, BL, Howie, LJ, Singh, H and Kluetz, PG 2019 , 'Blinding and patient-reported outcome completion rates in US Food and Drug Administration cancer trial submissions, 2007-2017' , Journal of the National Cancer Institute, vol. 111, no. 5 , pp. 459-464 , doi: https://doi.org/10.1093/jnci/djy181.

Roydhouse, J ORCID: 0000-0002-8025-5841, King-Kallimanis, BL, Howie, LJ, Singh, H and Kluetz, PG 2019 , 'Blinding and patient-reported outcome completion rates in US Food and Drug Administration cancer trial submissions, 2007-2017' , Journal of the National Cancer Institute, vol. 111, no. 5 , pp. 459-464 , doi: https://doi.org/10.1093/jnci/djy181.

Roydhouse, J, King-Kallimanis, BL, Roy, P, Weinstock, C, Krol, D, Daniels, SR, Suzman, DL, Beaver, JA and Kluetz, PG 2020 , 'Exploration of baseline patient-reported side effect bother from cancer therapy' , Clinical Trials , pp. 1-6 , doi: https://doi.org/10.1177/1740774520910389.

Roydhouse, J, Suzman, DL, Menapace, LA, Mishra-Kalyani, PS, Sridhara, R, Blumenthal, GM, Beaver, JA, Pazdur, R and Kluetz, PG 2019 , 'Global variation in Opioid use in prostate cancer trials' , JAMA Oncology, vol. 5, no. 11 , doi: https://doi.org/10.1001/jamaoncol.2019.2971.

Roydhouse, JK ORCID: 0000-0002-8025-5841, Menapace, LA, Xia, H, Song, P, Berman, TJ, Agarwal, R, Suzman, DL, Wright, K, Beaver, JA and Kluetz, PG 2020 , 'Concomitant botanical medicine use among patients participating in commercial prostate cancer trials' , Complementary Therapies in Medicine , doi: https://doi.org/10.1016/j.ctim.2020.102549.

Roydhouse, JK ORCID: 0000-0002-8025-5841, Menapace, LA, Xia, H, Song, P, Berman, TJ, Agarwal, R, Suzman, DL, Wright, K, Beaver, JA and Kluetz, PG 2020 , 'Concomitant botanical medicine use among patients participating in commercial prostate cancer trials' , Complementary Therapies in Medicine, vol. 54 , pp. 1-8 , doi: https://doi.org/10.1016/j.ctim.2020.102549.

Roydhouse, JK ORCID: 0000-0002-8025-5841, Mishra-Kalyani, PS, Bhatnagar, V, Gutman, R, King-Kallimanis, BL, Sridhara, R and Kluetz, PG 2021 , 'Does knowledge of treatment assignment affect patient report of symptoms, function, and health status? An evaluation using multiple myeloma trials' , Value in Health , doi: https://doi.org/10.1016/j.jval.2020.12.015.

This list was generated on Thu Jun 1 01:37:15 2023 AEST.
TOP